Biotech Values

[oc631]

Are you saying that IDIX disclosed an AE with respect to the IDX320 monotherapy Phase 1 during today's call? I am trying to clarify if you are talking about today's call (which again, I haven't listened to yet) or if you are saying this 320 AE was disclosed during a prior call.

Let's just call it an event that was discussed today in the 3-day study. I asked the same question in an earlier post today, about an AE, and we need more clarity on this. It seems they now regret pushing the dose to 400mg but there were no liver tox signals in animal testing.